Specialized Industry Focus SIGMA Process & Automation GmbH has a strong specialization in process automation solutions for highly regulated and innovative sectors such as Pharma, Biotechnology, Diagnostics, and Chemical industries, indicating a tailored approach that can be leveraged to address complex industry-specific automation needs.

Recent Acquisition As part of the ZETA Group acquisition completed in October 2025, SIGMA now benefits from broader global reach and resources, presenting opportunities for upselling integrated automation solutions across new markets and customer segments within the pharmaceutical and biotech sectors.

Technological Expertise The company's advanced tech stack, including Siemens hardware, SCADA systems, Power BI, and programming languages like Python and C#, highlights its capability to deliver cutting-edge automation and manufacturing intelligence solutions, appealing to clients seeking innovative and reliable process systems.

Market Position and Growth With revenues between 10 and 25 million USD and a dedicated focus on process efficiency, safety, and sustainability, SIGMA offers growth opportunities for clients aiming to modernize their operations with customized automation systems that enhance process reliability and regulatory compliance.

Strategic Partnership Potential Being part of the ZETA Group enhances SIGMA's strategic leverage and opens avenues for collaborative projects, joint offerings, and cross-selling opportunities within the high-growth pharmaceutical and biotech automation markets, making it an attractive partner for organizations looking to expand their automation footprint.